Midas Pharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe and beyond. Founded in 1994, the company has established itself as a trusted partner in the development and distribution of innovative healthcare solutions. Midas Pharma focuses on contract development and manufacturing, offering a diverse range of services that include drug formulation, regulatory support, and supply chain management. Their commitment to quality and customer-centric approach sets them apart in a competitive market. With a strong emphasis on research and development, Midas Pharma has achieved significant milestones, positioning itself as a leader in the pharmaceutical sector. The company’s dedication to excellence is reflected in its robust portfolio of products and services, catering to the evolving needs of the healthcare landscape.
How does Midas Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Midas Pharma GmbH's score of 15 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Midas Pharma GmbH, headquartered in Germany, currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or climate pledges. As of now, Midas Pharma GmbH does not inherit emissions data from a parent company or related organization, indicating that their climate commitments and emissions reporting are independent. Without specific emissions data or reduction initiatives, it is unclear how the company is addressing climate change within its operations. In the absence of concrete figures or commitments, Midas Pharma's approach to sustainability and climate action remains unspecified, highlighting a potential area for future development in their environmental strategy.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Midas Pharma GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.